Extrapyramidal side effects associated with aripiprazole coprescription in 2 patients.
Cohen
S Tziporah
ST
Rulf
Daphne
D
Pies
Ronald
R
D000328:Adult; D017109:Akathisia, Drug-Induced / Q000209:etiology; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000068180:Aripiprazole; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D015363:Quinolones / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D020280:Sertraline / Q000493:pharmacokinetics / Q000627:therapeutic use
D014150:Antipsychotic Agents; D000068180:Aripiprazole; D010879:Piperazines; D015363:Quinolones; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline